secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2023-05-25T23:59:59+00:00
Accession:  0001493152-23-019096
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix receives NASDAQ deficiency notice for minimum stockholders' equity
-------------------------------------------------------------------------------

- Stockholders' equity of ~$2.2M as of March 31, 2023, is below NASDAQ's $2.5M minimum.
- Company does not meet alternative compliance standards ($35M market value or $500K net income).
- Must submit a plan to regain compliance by July 7, 2023; NASDAQ may grant up to 180-day extension.
- Failure to regain compliance could lead to delisting of common stock from Nasdaq Capital Market.
- Management intends to evaluate courses of action but provides no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315223019096/0001493152-23-019096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315223019096/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-019096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer